Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Northwell Health’s Constellation Gala raises more than $3M to support healthcare innovation in Manhattan

More than $3 million was raised at Northwell Health’s annual Constellation Gala, held virtually on November 9. The event celebrates philanthropic support as the driving force of innovations throughout Northwell Health that are transforming health care around the country.

Hosted by Colin Jost, co-head writer of “Saturday Night Live,” this year’s Constellation Gala featured special performances from the company of the Tony and Grammy Award-winning musical, “Dear Evan Hansen,” and the Northwell Health Nurse Choir. Attendees included New York City leaders from various industries and philanthropists and volunteer leaders who support Northwell’s Manhattan care sites.

Proceeds from the Constellation Gala will provide greater access to high-quality care by helping to advance innovative services and programs across Manhattan including at Lenox Hill Hospital; Manhattan Eye, Ear & Throat Hospital (MEETH); and Lenox Health Greenwich Village.

“The momentum and energy of Northwell’s presence in Manhattan is palpable,” said Michael Dowling, president and CEO of Northwell Health. “With more than 90 care facilities across the city, we are providing greater access to high-quality, convenient health care closer to the communities where people live.”

Serving Manhattan for more than 160 years, iconic Lenox Hill Hospital has been a cornerstone in the community. It offers world-class inpatient and surgical care at one of the most sophisticated hospitals in New York City, as well as seamless, convenient access to care at MEETH, Lenox Health Greenwich Village and nearby outpatient practices.

“The last two years through a pandemic have been so challenging for everyone, but Northwell came through stronger than ever and fulfilled its commitment to the community,” said Paul Guenther, chair of Northwell’s Western Regional Executive Council. “We never lost sight that it’s about making the lives of people better, and through the support of our donors, we can continue advancing our vision for quality care and innovation that makes a difference for our patients.”

Outpacing the Impossible campaign has raised more than $895 million

The event supported Northwell’s Outpacing the Impossible campaign, a $1 billion comprehensive fundraising effort to fuel innovation to advance health care and support Northwell’s promise to the people it serves. The campaign — which was publicly launched in October 2018 and to date, has raised more than $895 million — supports capital projects, improves hospitals and clinical programs, advances research and funds endowment for teaching and research initiatives.

Leading sponsors of the Constellation Gala included Ellen & Daniel M. Crown, Laura & Michael G. Fisch, Diane & Paul B. Guenther, Beth & Peter Hammack, Phyllis & William L. Mack, Iris & Michael Smith, Donald Zucker & Barbara Hrbek Zucker, Margaret M. Crotty & Rory Riggs and Tara & Roy J. Zuckerberg.


Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

4SC Receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA

Jason Loveridge, Ph.D., CEO of 4SC, commented: “Receiving orphan drug designation for resminostat provides us with a number of important benefits, most crucially 7 years’ market exclusivity in the US, a key foundation of our efforts to commercialise Kinselby.  We are currently preparing a marketing authorisation application for Kinselby in the EU, which remains on track for submission in Q1 2024.”

Abyrx Receives FDA Clearance for MONTAGE ® Settable Bone Putty for Use in Cardiothoracic Surgery

By expanding the range of FDA-cleared surgical applications for MONTAGE, this latest milestone positions Abyrx to build upon the more than 25,000 units of MONTAGE that have been used to date by surgeons in trauma, orthopedics, sports medicine, foot and ankle, and craniomaxillofacial procedures.

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

By using this website you agree to accept Medical Device News Magazine Privacy Policy